Columbia, TN, United States of America

Joel T Hargrove

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Genesis Systems LLC, Other. Active years: 1990-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel T Hargrove. Retrieved from https://idiyas.com/inventor/joel-t-hargrove

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 258(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Joel T Hargrove

Introduction

Joel T Hargrove is an accomplished inventor based in Columbia, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of premenstrual syndrome. With a total of 3 patents to his name, Hargrove's work has the potential to improve the quality of life for many individuals.

Latest Patents

Hargrove's latest patents focus on a pharmaceutical composition suitable for oral administration that comprises micronized progesterone in an oil vehicle high in glycerides of polyunsaturated fatty acids. This innovative method allows micronized progesterone particles to be absorbed more readily into the bloodstream, achieving high progesterone blood serum levels. The pharmaceutical composition can be readily formulated into capsules for effective treatment of premenstrual syndrome.

Career Highlights

Throughout his career, Hargrove has worked with various companies, including Genesis Systems LLC. His expertise in pharmaceutical formulations has positioned him as a valuable contributor to the industry.

Collaborations

Hargrove has collaborated with notable individuals such as Wayne S Maxson and Philip G Meyers. These partnerships have further enhanced his innovative work in the field.

Conclusion

Joel T Hargrove's contributions to pharmaceutical innovations, particularly in the treatment of premenstrual syndrome, highlight his dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and providing effective solutions for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…